Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Capsaicin vs Semaglutide: Semaglutide has the stronger overall evidence (8.5 vs 5/10); they're alternatives for manage weight — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Semaglutide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (2)
Outcomes where both Capsaicin and Semaglutide have evidence — compare verdict strength side-by-side.
2-6mg capsaicinoids daily (meta-analysis suggests a minimum of ~2mg to affect energy intake); higher capsinoid doses used for thermogenesis
before-meals
Capsaicinoid extract (capsule)
Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.
any
Subcutaneous once-weekly injection (Ozempic / Wegovy)
Acute (per dose)
Acute (per meal)
Acute
Throughout use
Weeks to months
Months (titrated over 16-20 weeks)
Months to years
Especially during dose escalation
Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data.
Appetite (2014) · Meta analysis · n=191
Pooled 8 trials (191 participants), 19 effect sizes
The effect of Capsaicinoids or Capsinoids in red pepper on thermogenesis in healthy adults: A systematic review and meta-analysis.
Phytother Res (2021) · Meta analysis
Pooled 13 placebo-controlled trials
The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans.
Chem Senses (2012) · Meta analysis
Meta-analyses of thermogenic outcomes plus systematic review of appetite outcomes in humans
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).
N Engl J Med (2021) · Rct · n=1961
Double-blind RCT in 1,961 adults with obesity/overweight WITHOUT diabetes, randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo plus lifestyle for 68 weeks
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT).
N Engl J Med (2023) · Rct · n=17604
Large cardiovascular-outcomes RCT: 17,604 patients with preexisting cardiovascular disease and overweight/obesity but WITHOUT diabetes
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6).
N Engl J Med (2016) · Rct · n=3297
Pre-approval cardiovascular-safety RCT in 3,297 patients with type 2 diabetes at high cardiovascular risk, semaglutide (0.5/1.0 mg/week) vs placebo for 104 weeks
Semaglutide has a higher evidence score (8.5/10 vs 5/10) and wins in 2 of 3 categories.
For manage weight, Semaglutide has a higher relevance score (88 vs 50).
No known interactions between Capsaicin and Semaglutide have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.